A Comparison of Two Drug Reimbursement Pricing Models: B.C. Pharmacare and the Ontario Drug Benefit Programme

Paul Gorecki

Canadian Journal of Economics, 1993, vol. 26, issue 4, 867-77

Abstract: British Columbia's Pharmacare and the Ontario Drug Benefit Programme are compared with respect to drug prices, the market share of generic and brand names, and the existence of a difference between the government reimbursement price and the cost of the drug to the pharmacist. The evidence suggests that the best available price system of Ontario yields lower interchangeable drug prices than the actual acquisition cost system of British Columbia.

Date: 1993
References: Add references at CitEc
Citations:

Downloads: (external link)
http://links.jstor.org/sici?sici=0008-4085%2819931 ... COTDR%3E2.0.CO%3B2-L (text/html)
only available to JSTOR subscribers

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cje:issued:v:26:y:1993:i:4:p:867-77

Ordering information: This journal article can be ordered from
https://www.economic ... ionen/membership.php

Access Statistics for this article

Canadian Journal of Economics is currently edited by Zhiqi Chen

More articles in Canadian Journal of Economics from Canadian Economics Association Canadian Economics Association Prof. Werrner Antweiler, Treasurer UBC Sauder School of Business 2053 Main Mall Vancouver, BC, V6T 1Z2. Contact information at EDIRC.
Bibliographic data for series maintained by Prof. Werner Antweiler ().